Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/23/19 → 11/15/21 |
Funding
- Syneos Health, Inc. (Prot #2215-CL-1101 // Prot #2215-CL-1101)
- Astellas Pharma Global Development, Inc. (Prot #2215-CL-1101 // Prot #2215-CL-1101)
Prot #2215-CL-1101: Phase 1/2 Study of ASP2215 (Gilteritinib) Combined with Atezolizumab in Patients with Relapsed or Treatment Refractory FLT3 Mutated Acute Myeloid Leukemia (AML)
- Altman, Jessica K (PD/PI)
Project: Research project